TrianglePUBLICATIONS · 19349550
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Jun 20
- First author
- Vahdat LT
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Vahdat LT
- type
- Author
- name
- Pruitt B
- type
- Author
- name
- Fabian CJ
- type
- Author
- name
- Rivera RR
- type
- Author
- name
- Smith DA
- type
- Author
- name
- Tan-Chiu E
- type
- Author
- name
- Wright J
- type
- Author
- name
- Tan AR
- type
- Author
- name
- Dacosta NA
- type
- Author
- name
- Chuang E
- type
- Author
- name
- Smith J
- type
- Author
- name
- O'Shaughnessy J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Vahdat LT
- type
- Author
- name
- Pruitt B
- type
- Author
- name
- Fabian CJ
- type
- Author
- name
- Rivera RR
- type
- Author
- name
- Smith DA
- type
- Author
- name
- Tan-Chiu E
- type
- Author
- name
- Wright J
- type
- Author
- name
- Tan AR
- type
- Author
- name
- Dacosta NA
- type
- Author
- name
- Chuang E
- type
- Author
- name
- Smith J
- type
- Author
- name
- O'Shaughnessy J
- type
- Author
- bibliography ids
- nci-bib-f75a3ce0892c2f85c742ef6d
- book metadata
- content sha256
- f43b39f7773a6a28ba399d9338011c1645a6fb0722eeba1792a2f2f44d1f12b5
- document type
- citation
- dois
- 10.1200/JCO.2008.17.7618
- electronic publication date
- display
- 2009 Apr 6
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19349550
- immutable id
- pubmed:19349550@f43b39f7773a6a28ba399d9338011c1645a6fb0722eeba1792a2f2f44d1f12b5
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 18
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2954-61
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19349550
- provenance
- batch id
- 4f803f1a8e7b4f56d2f1
- provider
- NCBI PubMed ESummary
- record sha256
- 7b8ab80a232db993a13c9b3019aa82c0e6b29a5197be3c79feee43990586f846
- response sha256
- fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
- retrieved at
- 2026-09-09T23:46:26.391289+00:00
- publication date
- display
- 2009 Jun 20
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
Preserved source evidence · Not medical advice